{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:37:02Z","timestamp":1794987422776,"version":"4.9.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n                  <jats:p>An estimated 150,000 youth and 1.4 million adults living in the United States identify as transgender. This Committee Opinion offers guidance on providing inclusive and affirming care as well as clinical information on hormone therapy and preventive care; it also cites existing resources for those seeking information on the care of transgender adolescents. The social and economic marginalization of transgender individuals is widespread, which leads to health care inequities and poorer health outcomes for this population. To reduce the inequities experienced by the transgender community, the provision of inclusive health care is essential. Obstetrician\u2013gynecologists should strive to make their offices open to and inclusive for all individuals and should seek out education to address health care disparities, both in their individual practices and in the larger health care system. In order to provide the best care for patients, it is useful to know which health care professionals to include in a referral network for primary care and to have many clinician and surgeon options given the many different therapies available and the different sites at which these therapies are offered. It is important to remember that although hormone therapy is a medically necessary treatment for many transgender individuals with gender dysphoria, not all transgender patients experience gender dysphoria and not everyone desires hormone treatment. Gender-affirming hormone therapy is not effective contraception. Sexually active individuals with retained gonads who do not wish to become pregnant or cause pregnancy in others should be counseled about the possibility of pregnancy if they are having sexual activity that involves sperm and oocytes. Although being knowledgeable about the medications used for gender transition and potential risks and side effects is important, specific certification for prescribing them is not required and should not be a limiting factor in helping patients access care.<\/jats:p>","DOI":"10.1097\/aog.0000000000004294","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T16:00:55Z","timestamp":1614355255000},"page":"e75-e88","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":154,"title":["Health Care for Transgender and Gender Diverse Individuals"],"prefix":"10.1097","volume":"137","member":"276","reference":[{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"e107104","DOI":"10.1371\/journal.pone.0107104","article-title":"Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers","volume":"9","author":"Cahill","year":"2014","journal-title":"PLoS One"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000000540","article-title":"Transgender men who experienced pregnancy after female-to-male gender transitioning","volume":"124","author":"Light","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jmwh.12213","article-title":"Conception, pregnancy, and birth experiences of male and gender variant gestational parents: it's how we could have a family","volume":"60","author":"Ellis","year":"2015","journal-title":"J Midwifery Womens Health"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/IJWH.S232693","article-title":"Is cabergoline safe and effective for postpartum lactation inhibition? A systematic review","volume":"12","author":"Yang","year":"2020","journal-title":"Int J Womens Health"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical practice guideline [published errata appear in J Clin Endocrinol Metab 2018;103:2758\u201359; J Clin Endocrinol Metab 2018;103:699]","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/trgh.2017.0044","article-title":"Case report: induced lactation in a transgender woman","volume":"3","author":"Reisman","year":"2018","journal-title":"Transgend Health"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","year":"2016","journal-title":"Transl Androl Urol"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/AOG.0000000000001866","article-title":"Feasibility of vaginal hysterectomy for female-to-male transgender men","volume":"129","author":"Obedin-Maliver","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/AOG.0000000000002296","article-title":"Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R28-20250423","first-page":"e111","article-title":"Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self-versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","article-title":"Endometrial cancer. Practice Bulletin No. 149. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R32-20250423","first-page":"1901","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement [published erratum appears in JAMA 2018;319:2443]","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/aogs.12618","article-title":"Sex reassignment of transsexual people from a gynecologist's and urologist's perspective","volume":"94","author":"Trum","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","article-title":"Breast cancer development in transsexual subjects receiving cross-sex hormone treatment","volume":"10","author":"Gooren","year":"2013","journal-title":"J Sex Med"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejrad.2009.03.018","article-title":"Mammography and breast sonography in transsexual women","volume":"74","author":"Weyers","year":"2010","journal-title":"Eur J Radiol"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/lgbt.2016.0113","article-title":"Disparities in exposure to intimate partner violence among transgender\/gender nonconforming and sexual minority primary care patients","volume":"4","author":"Valentine","year":"2017","journal-title":"LGBT Health"},{"issue":"RR-03","key":"R37-20250423","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015. Centers for Disease Control and Prevention [published erratum appears in MMWR Recomm Rep. 2015;64:924]","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.AOG.0000446855.78026.21","article-title":"Preexposure prophylaxis for the prevention of human immunodeficiency virus. Committee Opinion No. 595. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000004684","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:01:58Z","timestamp":1745420518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004294"}},"subtitle":["ACOG Committee Opinion, Number 823"],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004294","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}